| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ENE.13496 |
| P698 | PubMed publication ID | 29053903 |
| P50 | author | Anand Venkatraman | Q42830325 |
| P2093 | author name string | N Patel | |
| P Arora | |||
| G Arora | |||
| S Hardas | |||
| N Singh Bajaj | |||
| P2860 | cites work | Prognostic biomarkers in acute coronary syndrome | Q26738521 |
| The Role of Galectin-3 in the Kidneys | Q26752754 | ||
| Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis | Q26771826 | ||
| 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines | Q26864648 | ||
| Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation | Q28290361 | ||
| Galectin-3 mediates post-ischemic tissue remodeling | Q28578907 | ||
| Galectin-3 maintains cell motility from the subventricular zone to the olfactory bulb. | Q30501653 | ||
| Who let the dogs out?: detrimental role of Galectin-3 in hypoperfusion-induced retinal degeneration | Q30656553 | ||
| Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. | Q34436922 | ||
| Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. | Q34538268 | ||
| Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis | Q35026202 | ||
| Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. | Q35302064 | ||
| Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. | Q35574021 | ||
| Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 | ||
| Evolution of blood-brain-barrier permeability after acute ischemic stroke | Q36282432 | ||
| Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice | Q36357458 | ||
| Cellular mechanisms of neurovascular damage and repair after stroke | Q36488682 | ||
| Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia | Q36937939 | ||
| Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage | Q37339791 | ||
| Blocked angiogenesis in Galectin-3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke | Q38310962 | ||
| Glycohistochemical characterization of vascular muscle cell destruction in CADASIL subjects by lectins, neoglycoconjugates and galectin-specific antibodies. | Q38352132 | ||
| Galectin-3 and post-myocardial infarction cardiac remodeling. | Q38534975 | ||
| Paving the way for adequate myelination: The contribution of galectin-3, transferrin and iron. | Q38571180 | ||
| High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy | Q38915953 | ||
| Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort | Q39005503 | ||
| Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice | Q39191329 | ||
| Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke | Q39194291 | ||
| Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling | Q39224810 | ||
| Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway | Q39639082 | ||
| Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker. | Q40451658 | ||
| Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study | Q40615816 | ||
| Role of galectin-3 in plasma as a predictive biomarker of outcome after acute intracerebral hemorrhage | Q40616519 | ||
| Galectin-3 promotes neural cell adhesion and neurite growth | Q40990002 | ||
| Galectins: a family of animal lectins that decipher glycocodes | Q41201922 | ||
| Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. | Q42805774 | ||
| The Role of Galectin-3 as a Marker of Cancer and Inflammation in a Stage IV Ovarian Cancer Patient with Underlying Pro-Inflammatory Comorbidities | Q43073239 | ||
| Galectin-3 contributes to neonatal hypoxic-ischemic brain injury | Q43201355 | ||
| Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. | Q43489000 | ||
| Role of galectin-3 in prion infections of the CNS. | Q44545489 | ||
| Cardiovascular risk factors and cognitive function. | Q45930665 | ||
| The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). | Q48274713 | ||
| Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. | Q48427366 | ||
| The fibrosis marker galectin-3 and outcome in the general population | Q48821773 | ||
| Increase of galectin-3 expression in microglia by hyperthermia in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia | Q48880930 | ||
| Galectin-3 is not an outcome biomarker in ischemic stroke. Letter concerning the study 'Role of galectin-3 in plasma as a predictive biomarker of outcome after acute intracerebral hemorrhage. | Q51312721 | ||
| New onset atrial fibrillation is associated with elevated galectin-3 levels. | Q51568519 | ||
| Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. | Q53630691 | ||
| Inflammatory Gene Profiling in the Developing Mouse Brain After Hypoxia-Ischemia | Q57982839 | ||
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 238-246 | |
| P577 | publication date | 2017-10-20 | |
| P1433 | published in | European Journal of Neurology | Q15757256 |
| P1476 | title | Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases | |
| P478 | volume | 25 |
| Q92074847 | Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1 |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q92004321 | Investigation of galectin-3, lipocalin 2, retinol binding protein (RBP), small dense low-density lipoprotein (sdLDL) in patients with hirsutism |
| Q50133781 | Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage |
Search more.